Ampio Pharmaceuticals, Inc. (AMPE) has an overall financial health rating of B- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-12-30.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-12-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-12-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-12-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-12-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-12-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-11-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-11-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-11-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-11-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
